The prospects of glycan biomarkers for the diagnosis of diseases.
暂无分享,去创建一个
[1] Y. Mechref,et al. Alterations in the serum glycome due to metastatic prostate cancer. , 2007, Journal of proteome research.
[2] R Apweiler,et al. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.
[3] Kit S. Lam,et al. A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.
[4] Y. Mechref,et al. Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. , 2008, Journal of proteome research.
[5] C. Bertozzi,et al. Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.
[6] Carlito Lebrilla,et al. Nanoliquid chromatography‐mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high‐accuracy mass analyzer , 2005, Electrophoresis.
[7] I. Brockhausen. Pathways of O-glycan biosynthesis in cancer cells. , 1999, Biochimica et biophysica acta.
[8] N. Packer,et al. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions. , 2005, The Biochemical journal.
[9] E. Go,et al. Maximizing coverage of glycosylation heterogeneity in MALDI-MS analysis of glycoproteins with up to 27 glycosylation sites. , 2008, Analytical chemistry.
[10] Pauline M Rudd,et al. The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.
[11] K. Lam,et al. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? , 2007, International Journal of Gynecologic Cancer.
[12] Hyun Joo An,et al. Determination of N-glycosylation sites and site heterogeneity in glycoproteins. , 2003, Analytical chemistry.
[13] Kit S Lam,et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. , 2006, Journal of proteome research.
[14] Pauline M Rudd,et al. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. , 2003, Glycobiology.
[15] Terence C W Poon,et al. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. , 2006, Journal of proteome research.
[16] P. Seeberger,et al. The utility of carbohydrate microarrays in glycomics. , 2006, Omics : a journal of integrative biology.
[17] Hyun Joo An,et al. Improved capillary electrophoretic separation and mass spectrometric detection of oligosaccharides. , 2003, Journal of chromatography. A.
[18] Kerby Shedden,et al. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. , 2007, Journal of proteome research.
[19] A. Kuno,et al. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling , 2005, Nature Methods.
[20] Tasneem H. Patwa,et al. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. , 2006, Analytical chemistry.
[21] J. Esko,et al. The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.
[22] R. Alon,et al. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions , 2001, Glycoconjugate Journal.
[23] Jakob Bunkenborg,et al. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. , 2004, Journal of proteome research.